Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Tyra Biosciences, Inc. (TYRA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Tyra Biosciences, Inc. (TYRA), most recent 12 months reported: net loss $148.56M, free cash flow -$109.9M. Latest balance sheet on file: liquid cash $353.94M. From SEC filings. Others in Pharmaceutical Preparations: TRAFALGAR INTERNATIONAL, INC. · Trevi Therapeutics, Inc. · Turn Therapeutics Inc. · TVARDI THERAPEUTICS, INC. · UNICYCIVE THERAPEUTICS, INC. · Valion Bio, Inc. · Vera Therapeutics, Inc. · VERU INC.

Stock screener

Watchlist